Table 4.
Mean life-years lost for Iranian patients with T2DM, compared to the general population using 2004 national life table.
| Age at diagnosis | Male | Life-years losta | Female | Life-years losta | Total | Life-years losta |
|---|---|---|---|---|---|---|
| Number | Mean (SD) | Number | Mean (SD) | Number | Mean (SD) | |
| <40 | 59 | 20.2 (7.1) | 35 | 21.8 (5.4) | 94 | 20.8 (6.5) |
| 40–44 | 45 | 16.5 (6.6) | 59 | 17.8 (5.2) | 104 | 17.2 (5.8) |
| 45–49 | 66 | 15.5 (5.2) | 58 | 15.3 (5.1) | 124 | 15.4 (5.1) |
| 50–54 | 70 | 12.2(4.5) | 56 | 12.9 (4.1) | 126 | 12.5 (4.3) |
| 55–59 | 76 | 11.1 (3.2) | 50 | 11.3 (3.0) | 126 | 11.2 (3.1) |
| 60–64 | 44 | 8.7 (2.6) | 37 | 9.4 (2.8) | 81 | 9.0 (2.7) |
| 65–69 | 36 | 7.2 (2.1) | 22 | 7.2 (2.0) | 58 | 7.2 (2.1) |
| 70–74 | 8 | 5.4 (1.5) | 9 | 5.1 (1.5) | 17 | 5.3 (1.4) |
| ≥ 75 | 2 | 3.1 (0.0) | 0 | — | 2 | 3.1 (0.0) |
| Total | 406 | 13.2 (6.3) | 326 | 13.9 (6.0) | 732 | 13.5 (6.2) |
aLife-years lost were estimated for each deceased person by subtracting the age of death for each deceased person from his/her expected years of life.